{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T08:32:38Z","timestamp":1771230758878,"version":"3.50.1"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Eskisehir Osmangazi University, Turkey"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Tissue and Cell"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.tice.2019.07.001","type":"journal-article","created":{"date-parts":[[2019,7,2]],"date-time":"2019-07-02T19:27:03Z","timestamp":1562095623000},"page":"62-69","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Azoramide ameliorates fructose-induced nonalcoholic fatty liver disease in mice"],"prefix":"10.1016","volume":"59","author":[{"given":"Ridvan","family":"Bagci","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Varol","family":"Sahinturk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erhan","family":"Sahin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.tice.2019.07.001_bib0005","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1161\/01.HYP.0000164570.20420.67","article-title":"Fructose-induced fatty liver disease: hepatic effects of blood pressure and plasma triglyceride reduction","volume":"45","author":"Ackerman","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.tice.2019.07.001_bib0010","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S1665-2681(19)31822-8","article-title":"Metabolic syndrome and non-alcoholic fatty liver disease","volume":"8","author":"Almeda-Vald\u00e9s","year":"2009","journal-title":"Ann. Hepatol."},{"key":"10.1016\/j.tice.2019.07.001_bib0015","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.biopha.2018.11.079","article-title":"Raspberry ketone and Garcinia Cambogia rebalanced disrupted insulin resistance and leptin signaling in rats fed high fat fructose diet","volume":"110","author":"Attia","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.tice.2019.07.001_bib0020","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/1440-1681.13074","article-title":"Resveratrol protects against hepatic insulin resistance in a rat\u2019s model of non-alcoholic fatty liver disease by down-regulation of GPAT-1 and DGAT2 expression and inhibition of PKC membranous translocation","volume":"46","author":"Badi","year":"2019","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.tice.2019.07.001_bib0025","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1093\/ajcn\/72.5.1128","article-title":"Effects of dietary fructose on plasma lipids in healthy subjects\u2013","volume":"72","author":"Bantle","year":"2000","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.tice.2019.07.001_bib0030","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.livres.2018.03.001","article-title":"Rodent models of fatty liver diseases","volume":"2","author":"Bertola","year":"2018","journal-title":"Liver Res."},{"key":"10.1016\/j.tice.2019.07.001_bib0035","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jnutbio.2013.10.010","article-title":"Role of immunodeficient animal models in the development of fructose induced NAFLD","volume":"25","author":"Bhattacharjee","year":"2014","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.tice.2019.07.001_bib0040","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.tem.2012.06.003","article-title":"New insights into ER stress-induced insulin resistance","volume":"23","author":"Flamment","year":"2012","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.tice.2019.07.001_bib0045","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaa9134","article-title":"Phenotypic assays identify azoramide as a small-molecule modulator of the unfolded protein response with antidiabetic activity","volume":"7","author":"Fu","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.tice.2019.07.001_bib0050","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.arcmed.2005.01.005","article-title":"Regulation of plasma triglycerides in insulin resistance and diabetes","volume":"36","author":"Ginsberg","year":"2005","journal-title":"Arch. Med. Res."},{"key":"10.1016\/j.tice.2019.07.001_bib0055","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.plefa.2018.11.005","article-title":"Medium-chain triglyceride reinforce the hepatic damage caused by fructose intake in mice","volume":"140","author":"Guimar\u00e3es","year":"2019","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"10.1016\/j.tice.2019.07.001_bib0060","first-page":"321","article-title":"The unfolded protein response in fatty liver disease, Seminars in liver disease","author":"Henkel","year":"2013","journal-title":"NIH Public Access"},{"key":"10.1016\/j.tice.2019.07.001_bib0065","doi-asserted-by":"crossref","first-page":"230","DOI":"10.3390\/nu9030230","article-title":"Fructose and NAFLD: the multifaceted aspects of fructose metabolism","volume":"9","author":"Jegatheesan","year":"2017","journal-title":"Nutrients"},{"key":"10.1016\/j.tice.2019.07.001_bib0070","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1172\/JCI37007","article-title":"GRP78 expression inhibits insulin and ER stress\u2013induced SREBP-1c activation and reduces hepatic steatosis in mice","volume":"119","author":"Kammoun","year":"2009","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tice.2019.07.001_bib0075","doi-asserted-by":"crossref","first-page":"11963","DOI":"10.3390\/ijms140611963","article-title":"In vitro and in vivo models of non-alcoholic fatty liver disease (NAFLD)","volume":"14","author":"Kanuri","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tice.2019.07.001_bib0080","doi-asserted-by":"crossref","first-page":"4442","DOI":"10.1038\/s41598-017-02960-1","article-title":"XBP1-FoxO1 interaction regulates ER stress-induced autophagy in auditory cells","volume":"7","author":"Kishino","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tice.2019.07.001_bib0085","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.tice.2019.07.001_bib0090","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.ymeth.2004.10.010","article-title":"The ER chaperone and signaling regulator GRP78\/BiP as a monitor of endoplasmic reticulum stress","volume":"35","author":"Lee","year":"2005","journal-title":"Methods"},{"key":"10.1016\/j.tice.2019.07.001_bib0095","first-page":"102","article-title":"Pharmacological ER stress promotes hepatic lipogenesis and lipid droplet formation","volume":"4","author":"Lee","year":"2012","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.tice.2019.07.001_bib0100","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"10.1016\/j.tice.2019.07.001_bib0105","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/j.1753-0407.2009.00045.x","article-title":"Genistein improves liver function and attenuates non-alcoholic fatty liver disease in a rat model of insulin resistance","volume":"1","author":"Mohamed Salih","year":"2009","journal-title":"J. Diabetes"},{"key":"10.1016\/j.tice.2019.07.001_bib0110","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1126\/science.1128294","article-title":"Chemical chaperones reduce ER stress and restore glucose homeostasis in a mouse model of type 2 diabetes","volume":"313","author":"Ozcan","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.tice.2019.07.001_bib0115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0021041","article-title":"The definition of insulin resistance using HOMA-IR for Americans of Mexican descent using machine learning","volume":"6","author":"Qu","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.tice.2019.07.001_bib0120","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s13287-018-0771-y","article-title":"Azoramide, a novel regulator, favors adipogenesis against osteogenesis through inhibiting the GLP-1 receptor-PKA-beta-catenin pathway","volume":"9","author":"Ruan","year":"2018","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.tice.2019.07.001_bib0125","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.celrep.2013.10.007","article-title":"SIRT7 represses Myc activity to suppress ER stress and prevent fatty liver disease","volume":"5","author":"Shin","year":"2013","journal-title":"Cell Rep."},{"key":"10.1016\/j.tice.2019.07.001_bib0130","doi-asserted-by":"crossref","DOI":"10.1111\/bph.14573","article-title":"Pterostilbene prevents hepatocyte EMT in fructose\u2010induced liver fibrosis through suppressing miR\u201034a\/Sirt1\/p53 and TGF\u2010\u03b21\/Smads signaling","author":"Song","year":"2019","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.tice.2019.07.001_bib0135","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.3748\/wjg.v20.i7.1768","article-title":"Role of endoplasmic reticulum stress in the pathogenesis of nonalcoholic fatty liver disease","volume":"20","author":"Zhang","year":"2014","journal-title":"World J. Gastroenterol."}],"container-title":["Tissue and Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040816619301946?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040816619301946?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T20:18:04Z","timestamp":1758572284000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0040816619301946"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":27,"alternative-id":["S0040816619301946"],"URL":"https:\/\/doi.org\/10.1016\/j.tice.2019.07.001","relation":{},"ISSN":["0040-8166"],"issn-type":[{"value":"0040-8166","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Azoramide ameliorates fructose-induced nonalcoholic fatty liver disease in mice","name":"articletitle","label":"Article Title"},{"value":"Tissue and Cell","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tice.2019.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}